Essex is the number two university in the UK for the number of Innovate UK-funded projects, and ranks as the leading university in the East of England and London for leveraging R&D grant funding, to collaborate with businesses helping them to drive innovation, improve productivity and ultimately grow.
The university has expertise in the research areas of protein structure and the mechanisms of disease working to establish the link between structure and the physiological function of proteins with research spanning from individual atoms and isolated molecules to cellular biology approaches including pre-clinical models of cancer and immunology. Further fields of expertise are in genetics and computational biology with particular strengths in epigenetics and chromatin structure.
The university has expertise in the research areas of protein structure and the mechanisms of disease working to establish the link between structure and the physiological function of proteins with research spanning from individual atoms and isolated molecules to cellular biology approaches including pre-clinical models of cancer and immunology. Further fields of expertise are in genetics and computational biology with particular strengths in epigenetics and chromatin structure.
ValiRx Plc is a biopharmaceutical company developing novel technologies and products in oncology therapeutics and diagnostics. The product focus is in the epigenomic analysis and treatment of cancer, but the technologies can be applied to other fields as well, such as neurology and inflammatory diseases.. . The ValiRx management team comprises a mix of entrepreneurial scientists who are founders of a number of medical life sciences companies and industry-specific personnel, all with extensive experience in transferring technologies and products into the commercial arena to generate revenue and growth of shareholder value.
Watch our Member Showcase Video https://bit.ly/3fB4WZq
Watch our Member Showcase Video https://bit.ly/3fB4WZq
VasoDynamics is a Stevenage and London based, clinical-stage pharmaceutical development company. We are solely focused on developing patient-friendly, cost-effective medicines to prevent the severe side-effects induced by anticancer therapies. Our programmes are designed to prevent the common complications of cancer therapy, including mouth ulceration, dermatitis, and (permanent) hair-loss. Our philosophy is to generate affordable medicines that enable cancer patients to tolerate widely used anticancer therapies, with the dual purpose of enhancing the efficacy of anti-cancer therapy and improving patients’ quality of life with cancer, without painful, traumatic or debilitating side-effects.
Veranova is a global leader in the development and manufacturing of specialist and complex APIs for pharma and biotech customers. We have over 50 years of experience navigating the challenges of the global healthcare industry, and nurturing long-standing, trusted customer relationships.
Under our Pharmorphix® brand, we have a proven track record of delivering excellence for customers in early drug development. By applying our world-leading understanding of solid form science, we can improve the properties and success rates of drug candidates for the pharmaceutical industry. Visit https://www.veranova.com to discover more.
Watch Our Youtube Video: https://www.youtube.com/watch?v=ql3hyeQm-gE
/>
Under our Pharmorphix® brand, we have a proven track record of delivering excellence for customers in early drug development. By applying our world-leading understanding of solid form science, we can improve the properties and success rates of drug candidates for the pharmaceutical industry. Visit https://www.veranova.com to discover more.
Watch Our Youtube Video: https://www.youtube.com/watch?v=ql3hyeQm-gE
/>
Vernalis Research develop and apply fragment and structure-based methods to solve problems in drug discovery, and have generated cell active lead compounds and development candidates against targets in oncology, neurodegeneration, anti-infectives and inflammation.
The Company balances an internal portfolio of drug discovery projects with fully integrated research collaborations on targets with pharmaceutical companies and academic partners. Its shared-risk approach ensures a high level of engagement from our scientists and rewards success. Current disclosed collaborations include those with Servier, Daiichi Sankyo, Lundbeck and Asahi Kasei Pharma, and they seek additional partnerships.
Vernalis Research also have an extensive portfolio of partnered and unpartnered drug candidates in pre-clinical and clinical development.
The Company balances an internal portfolio of drug discovery projects with fully integrated research collaborations on targets with pharmaceutical companies and academic partners. Its shared-risk approach ensures a high level of engagement from our scientists and rewards success. Current disclosed collaborations include those with Servier, Daiichi Sankyo, Lundbeck and Asahi Kasei Pharma, and they seek additional partnerships.
Vernalis Research also have an extensive portfolio of partnered and unpartnered drug candidates in pre-clinical and clinical development.
VirdisGroup is a leading executive search firm specialising in the LifeScience and Healthcare sectors. . Partnering with clients throughout the world, our focus is to identify, engage and help hire top talent from senior executive to board level. However, we support our partners in building their teams and capabilities throughout the organisation. We are respected for our strong international networks and knowledge.. We have direct experience within the following sectors:. Pharmaceutical, Biotechnology, Capital Investors, Universities, CROs, Government, Animal Health, Diagnostics, Healthcare Services, MedTech, Research Consortia, Public-Private Partnerships
No data available
No data available
Choosing the right patent attorney to protect your valuable intellectual property can be a daunting task. Withers and Rogers is one of the foremost providers of intellectual property protection services in the United Kingdom and Europe. Each Withers and Rogers attorney is selected on the basis of excellent academic achievement and industry knowledge. When choosing a UK patent attorney or trade mark attorney, we hope you will consider us for our experience, client focus and professionalism. . . Withers & Rogers has a breadth and depth of experience and expertise that we believe is second to none. In addition to our practice groups, we have a number of specialist groups, enabling us to pool our industry knowledge and bring added value for our clients. . . How we work. We start by understanding your needs and helping you to maximise the success of your products, services and brands through the effective use of intellectual property. In a commercial world, we understand that you are looking for efficient and effective intellectual property strategies, backed by practical advice and support. This is always our priority. . . Principal practice groups . •Life Sciences and Chemistry group . •Advanced Engineering group . •Electronics Computing and Physics group . •Trade Mark group
WuXi AppTec is a leading open-access R&D capability and technology platform with operations in China, USA, Germany and Iceland. As an innovation-driven and customer-focused company, WuXi AppTec provides a broad and integrated portfolio of services to help our partners shorten the discovery and development time and lower the cost of drug and medical device R&D through cost-effective and efficient solutions. With its industry-leading capabilities in small molecule, biologics, cell therapy and gene therapy, medical device testing, and molecular testing and genomics, WuXi is enabling more than 2000 collaborators from more than 30 countries to bring innovative healthcare products to patients.